Medical breakthrough for multiple sclerosis
On 14 November 2011, it was announced that trials into a new drug, alemtuzumab, have been successful – a significant development for those suffering from multiple sclerosis (MS).
The Freemasons’ Grand Charity gave £100,000 towards this research in 2010, at the University of Cambridge.
Read Full Article on The Freemasons’ Grand Charity website